These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 663245)
1. Benefit/risk analysis of aggressive mammographic screening. Fox SH; Moskowitz M; Saenger EL; Kerelakes JG; Milbrath J; Goodman MW Radiology; 1978 Aug; 128(2):359-65. PubMed ID: 663245 [TBL] [Abstract][Full Text] [Related]
2. Cost analysis of aggressive breast cancer screening. Moskowitz M; Fox SH Radiology; 1979 Jan; 130(1):253-6. PubMed ID: 103136 [TBL] [Abstract][Full Text] [Related]
3. Mammographic screening of women aged 40 to 49 years. Is it justified? Feig SA Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636 [TBL] [Abstract][Full Text] [Related]
4. [Systematic mammographic screening for breast cancer in asymptomatic women]. Bourdon C; Mazy G; Vandenbroucke A J Belge Radiol; 1992 Feb; 75(1):17-23. PubMed ID: 1568999 [TBL] [Abstract][Full Text] [Related]
5. Estimating risk of breast cancer from population incidence affected by widespread mammographic screening. Taylor R; Boyages J J Med Screen; 2001; 8(2):73-6. PubMed ID: 11480447 [TBL] [Abstract][Full Text] [Related]
6. The value of mammography screening in women under age 50 years. Eddy DM; Hasselblad V; McGivney W; Hendee W JAMA; 1988 Mar; 259(10):1512-9. PubMed ID: 3123720 [TBL] [Abstract][Full Text] [Related]
7. [Risk-benefit analysis for mass screening of breast cancer utilizing mammography as a screening test]. Iinuma TA; Tateno Y Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Sep; 49(9):1091-5. PubMed ID: 2587191 [TBL] [Abstract][Full Text] [Related]
8. Radiation risk and mammographic screening of women from 40 to 49 years of age: effect on breast cancer rates and years of life. Mattsson A; Leitz W; Rutqvist LE Br J Cancer; 2000 Jan; 82(1):220-6. PubMed ID: 10638993 [TBL] [Abstract][Full Text] [Related]
9. [Mammographic examinations in Denmark, 1990-1991]. Andreasen AH; Andersen KW; Madsen M; Mouridsen HT; Olesen KP; Lynge E Ugeskr Laeger; 1994 Oct; 156(44):6517-20. PubMed ID: 7825250 [TBL] [Abstract][Full Text] [Related]
10. Mammography screening controversies. Miller AB Cancer Detect Prev; 1994; 18(4):305-11. PubMed ID: 7982240 [TBL] [Abstract][Full Text] [Related]
11. Implementation of breast cancer screening. Pisano ED; McLelland R Curr Opin Radiol; 1991 Aug; 3(4):579-87. PubMed ID: 1909543 [TBL] [Abstract][Full Text] [Related]
12. Medical audit of a rapid-throughput mammography screening practice: methodology and results of 27,114 examinations. Sickles EA; Ominsky SH; Sollitto RA; Galvin HB; Monticciolo DL Radiology; 1990 May; 175(2):323-7. PubMed ID: 2326455 [TBL] [Abstract][Full Text] [Related]
13. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. Curpen BN; Sickles EA; Sollitto RA; Ominsky SH; Galvin HB; Frankel SD AJR Am J Roentgenol; 1995 May; 164(5):1099-103. PubMed ID: 7717212 [TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey. Sabatino SA; Burns RB; Davis RB; Phillips RS; Chen YH; McCarthy EP Cancer; 2004 Jun; 100(11):2338-46. PubMed ID: 15160336 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of breast neoplasms detected on screening by mammography and physical examination. Feig SA; Schwartz GF; Nerlinger R; Edeiken J Radiology; 1979 Dec; 133(3 Pt 1):577-82. PubMed ID: 504635 [TBL] [Abstract][Full Text] [Related]
17. Impact of a mailed intervention on annual mammography and physician breast examinations among women at high risk of breast cancer. Richardson JL; Mondrus GT; Danley K; Deapen D; Mack T Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):71-6. PubMed ID: 8770470 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R; J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730 [TBL] [Abstract][Full Text] [Related]
19. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands. Zuur C; Broerse JJ Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229 [TBL] [Abstract][Full Text] [Related]
20. Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis. Krook PM AJR Am J Roentgenol; 1978 Dec; 131(6):1031-5. PubMed ID: 104567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]